Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,115 | 67,092 | 108,155 | 50,228 | 121,234 |
| Marketable Securities | 30,556 | 37,218 | 37,270 | 110,773 | 12,316 |
| Receivables | 2,013 | 2,178 | 3,181 | 6,571 | 8,917 |
| TOTAL | $103,705 | $110,053 | $152,050 | $171,505 | $146,643 |
| Non-Current Assets | |||||
| PPE Net | 82,439 | 81,810 | 82,146 | 83,676 | 33,430 |
| Intangibles | 27,938 | 28,238 | 28,538 | 28,838 | 29,138 |
| Other Non-Current Assets | 1,050 | 1,078 | 202 | 180 | 176 |
| TOTAL | $111,427 | $111,126 | $110,886 | $112,694 | $62,744 |
| Total Assets | $215,132 | $221,179 | $262,936 | $284,199 | $209,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 677 | 663 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,929 | 3,739 | 3,820 | 5,884 | 3,959 |
| Accrued Expenses | 6,691 | 5,327 | 3,811 | 4,757 | 7,862 |
| TOTAL | $32,132 | $27,361 | $27,527 | $31,766 | $22,650 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,120 | 37,289 | 56,344 | 56,344 | 4,000 |
| Deferred Revenues | 20,835 | 17,632 | 19,896 | 21,125 | 10,829 |
| Other Non-Current Liabilities | 1,205 | 1,082 | 3,426 | 3,306 | 614 |
| TOTAL | $61,010 | $57,517 | $82,627 | $86,217 | $8,251 |
| Total Liabilities | $93,142 | $84,878 | $110,154 | $117,983 | $30,901 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,064 | 9,062 | 9,051 | 9,047 | 8,972 |
| Common Shares | 63 | 63 | 63 | 63 | 63 |
| Retained earnings | -260,574 | -246,197 | -229,409 | -213,943 | -199,067 |
| Other shareholders' equity | -24 | -52 | -61 | -899 | -3,387 |
| TOTAL | $121,990 | $136,301 | $152,782 | $166,216 | $178,486 |
| Total Liabilities And Equity | $215,132 | $221,179 | $262,936 | $284,199 | $209,387 |